Cargando…
Cancer and Associated Therapies Impact the Skeletal Muscle Proteome
Introduction: Both cancer and cancer associated therapies (CAT; including chemotherapy or concurrent chemoradiation) disrupt cellular metabolism throughout the body, including the regulation of skeletal muscle mass and function. Adjunct testosterone therapy during standard of care chemotherapy and c...
Autores principales: | E. L., Dillon, T. J., Wright, A. R., Filley, A. B., Pulliam, K. M., Randolph, C. P., Danesi, C. R., Gilkison, J. E., Wiktorowicz, K. V., Soman, R. J., Urban, M, Sheffield-Moore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184684/ https://www.ncbi.nlm.nih.gov/pubmed/35694399 http://dx.doi.org/10.3389/fphys.2022.879263 |
Ejemplares similares
-
Proteomic investigation of human skeletal muscle before and after 70 days of head down bed rest with or without exercise and testosterone countermeasures
por: Dillon, E. Lichar, et al.
Publicado: (2019) -
Changes in Northern Elephant Seal Skeletal Muscle Following Thirty Days of Fasting and Reduced Activity
por: Wright, Traver J., et al.
Publicado: (2020) -
A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women
por: Wright, Traver J., et al.
Publicado: (2018) -
Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss
por: Sheffield-Moore, M., et al.
Publicado: (2013) -
Impact of Adjunct Testosterone on Cancer-Related Fatigue: An Ancillary Analysis from a Controlled Randomized Trial
por: McGovern, Kristen A., et al.
Publicado: (2022)